SGRY Surgery Partners Inc

📊🔥 Top Gainers Update 💰🚨 RTH 3:30pm ET Focusing on movers with the strongest fresh catalysts: $SGRY +47.56% – Definitive $5.7B acquisition agreement with HealthSpan Partners. Most shareholders will receive $23.50 cash per share, a major premium to Friday’s close. $XTND +25.71% – Preliminary 9-month revenue of $24.5M–$26.5M already exceeds FY2025 revenue, while AI Robotics backlog reached ~$84M. $LUCD +27.54% – Medicare reimbursement for EsoGuard at $1,938.01 per test remains the core commercial catalyst, supporting broader adoption potential. $CLRO +52.62% – Momentum-driven micro-cap move tied to renewed speculation around the pending Cortigent combination; Nasdaq delisting risk remains important. $GCTK +98.40% – Continued high-volatility momentum around the Lōkahi Therapeutics combination, with no stronger fresh same-day company catalyst identified.

Surgery Partners agreed to be acquired by HealthSpan Partners, an affiliate of nonprofit healthcare system Bon Secours Mercy Health, in an all-cash transaction valued at approximately $5.7 billion in enterprise value. Shareholders other than Bain Capital affiliates will receive $23.50 per share, representing a 49% premium to the previous close of $15.75. Bain Capital, which owns approximately 39% of Surgery Partners’ outstanding shares, will roll its stake into the acquiring entity rather than sell, remaining a significant partner after closing. The deal follows a failed 2025 attempt by Bain to take the company private at a higher enterprise valuation, underscoring the strategic appeal of Surgery Partners’ network of more than 176 surgical centers and hospitals across 30 U.S. states. A law firm specializing in investor rights has also launched an investigation into whether the transaction adequately compensates shareholders. $SGRY

$SGRY HealthSpan Partners is taking Surgery Partners private at 23.50 dollars a share, about 5.7 billion dollars in total and a 49% premium to Friday's close. Close is expected in Q1 2027. Bain owns 39% and agreed to vote for it, after its own take-private bid was rebuffed last year. That ends a two-year strategic review, with a nonprofit health system affiliate as the buyer instead.

HealthSpan Partners will acquire $SGRY for $23.50 per share in a $5.7B deal. Bain Capital rolls its stake. Close expected Q1 2027.

SGRY Stock Heads For Best Day In More Than 6 Years After HealthSpan Partners’ Acquisition Offer – Here’s What Investors Need To Know $SGRY https://stocktwits.com/news/equity/markets/sgry-stock-heads-for-best-day-in-more-than-6-years-after-health-span-partners-acquisition-offer/cZU3PnlRByt

$SGRY Follow-up: Surgery center operator's top holder Bain rolls 38.15% into $23.50 buyout. 🏢 Surgery Partners runs more than 200 locations in 30 states, including surgery centers and surgical hospitals, and was worth about $2.56 billion at the $19.525 trade at 08:16 ET on October 26, 2026; its September 17, 2026 8-K said it sold two Idaho hospitals for about $796.6 million to pay down debt 🤝 Bain Capital's funds, with 49,946,972 shares or 38.15%, said in an October 26 13D/A that they will vote for the merger and swap all their shares for equity in the buyer instead of taking cash ⚠️ The case against the premium is that public holders give up all upside after closing while Bain keeps its stake in the private company 📅 Next: Closing is expected in the first quarter of 2027, after holder and regulatory approvals; either side can walk if not done by July 23, 2027, a date that can be automatically extended in specified circumstances Source: SEC 13D/A + 8-K, Oct 26

$SGRY T1 halt, pending news. Wonder if they plan to announce something with regard to the Bons Secours rumors.

the weird one this morning: $SGRY is up ~23% premarket, 15.75 to ~19.42, on a Financial Times report that Bon Secours Mercy Health is close to taking a controlling stake at about 20 a share, roughly 6 billion dollars with debt. Bain would keep its ~40%. I found no company announcement or filing yet, so this is a report, not a signed deal. the stock is sitting just under the reported price.

$SGRY THE BIG QUESTION: Can SGRY break above $20, or will the reported takeover valuation limit further upside? Talks are not a completed deal. Terms, timing and shareholder treatment remain uncertain.

$SGRY SGRY Bon Secours Mercy Health Nears Deal for Majority Stake in Surgery Partners-FT Bon Secours Mercy Health is reportedly in late-stage talks to acquire a majority stake in Surgery Partners for roughly $20 per share, according to the Financial Times. The transaction would value the surgical care provider at approximately $6B including debt and would involve buying out part of Bain Capital’s position